Dyspnoea on the third day of puerperium: a case of peripartum cardiomyopathy
Keywords:
peripartum cardiomyopathy, heart failure, pregnancyAbstract
We report a case of a woman in the third day after delivery with acute heart failure. She’s diagnosed by transthoracic echocardiography of peripartum cardiomyopathy. Treatment of heart failure was started and the patient’s condition improved. Peripartum cardiomyopathy is the left ventricular systolic dysfunction that occurs in the final month of pregnancy and up to 5 months after delivery in abscense of another identifiable cause for the heart failure. Peripartum cardiomyopathy is the major cause of pregnancy-induced heart failure. Although the incidence is low, morbidity and mortality rates are high. Therefore, it’s necessary to take into consideration this pathology in the differential diagnosis.
Downloads
Metrics
References
Vest AR, Griffin BP, Raymond RE. Embarazo y enfermedades cardiovasculares. En: Griffin BP. Manual de Medicina Cardiovascular. 4ª edición. Barcelona. Lippincott, Williams & Wilkins; 2013: 224-236.
Hall ME, George EM, Granger JP. El corazón durante el embarazo. Rev Esp Cardiol. 2011: 64(11): 1045-1050.
Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010 Aug; 12(8): 767-778. doi: https://doi.org/10.1093/eurjhf/hfq120.
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32: 3147-3197.
Johnson-Coyle L, Jensen L, Sobey A, American College of Cardiology Foundation, American Heart Association. Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care Off Publ Am Assoc Crit-Care Nurses. 2012 Mar; 21(2): 89-98.
Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, et al.; IMAC-2 and IPAC Investigators. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016 Jan 21; 374(3): 233-41. doi: https://doi.org/10.1056/NEJMoa1505517.
Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J. 2015 May 7; 36(18): 1090-1097. doi: https://doi.org/10.1093/eurheartj/ehv009. Epub 2015 Jan 29.
Hilfiker-Kleiner D, Struman I, Hoch M, Podewski E, Sliwa K. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy. Curr Heart Fail Rep. 2012 Sep; 9(3): 174-182.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 M Povar-Echeverría, P Auquilla-Clavijo, A Pérez-Guerrero, RE Bautista-Alonso, J Moreno-Díaz
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
